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Prognostic Value of Multiple Draining 
lymph node Basins in Melanoma:  
a Matched-Pair analysis Based on 
the John Wayne cancer institute 
experience
J. Harrison Howard1,2*, Junko J. Ozao-Choy 1, Jason M. Hiles1, Myung-Shin Sim3  
and Mark B. Faries1
1 Department of Surgical Oncology, John Wayne Cancer Institute at Saint John’s Health Center, Santa Monica, CA,  
United States, 2 Division of Surgical Oncology, The Ohio State University, Columbus, OH, United States, 3 Department of 
Biostatistics, John Wayne Cancer Institute at Saint John’s Health Center, Santa Monica, CA, United States
Background: The prognostic significance of multiple draining basins is controversial in 
melanoma because analyses have not adequately controlled for standard prognostic 
variables. We hypothesized that an analysis based on prognostically matched pairs of 
patients with multiple versus single drainage basins would clarify any independent role 
of basin number.
study design: We identified patients in our 40-year prospective database, who underwent 
preoperative lymphoscintigraphy, intraoperative sentinel node biopsy and wide local exci-
sion for cutaneous melanoma. Overall survival (OS), disease-specific survival (DSS), and 
disease-free survival (DFS) were compared in patients with multiple versus single drainage 
basins after matching by age, sex, Breslow depth, primary site, and stage at diagnosis.
results: We identified 274 patients with multibasin drainage and 1,413 patients with 
single draining lymph node basins. Matching yielded 259 pairs (226 trunk, 27 head/neck, 
6 extremity). Among matched pairs, multibasin drainage did not affect rates of lymph 
node metastasis (p = 0.84), OS (p = 0.23), DSS (p = 0.53), overall recurrence (p = 0.65), 
locoregional recurrence (p = 0.58), or distant recurrence (p = 1.0). Multivariable analysis 
linked higher T stage, ulceration, older age, and lymph node positivity to decreased 
DSS (p < 0.01) and DFS (p < 0.001). Number of drainage basins was not significant on 
univariable or multivariable analysis.
conclusion: This analysis, the first to match for standard prognostic factors, suggests 
that multiplebasin drainage as identified by lymphoscintigraphy has no independent 
biological or prognostic significance in primary cutaneous melanoma.
Keywords: melanoma, multiple lymph node basin, sentinel lymph node biopsy, prognosis, survival rate
inTrODUcTiOn
Since the advent of lymphoscintigraphy for cutaneous melanoma it has become clear that some 
primary lesions will drain to more than one lymph node basin (1, 2). Reported rates of multibasin 
drainage (MBD) are 17–31% and vary related to the location of the primary lesion (3–6). Cutaneous 
melanomas of the truncal region are most likely to have MBD followed by lesions of the head and 
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neck, and rarely extremity lesions (3). Although sentinel lymph 
node (SLN) biopsy is recommended for each basin identified dur-
ing lymphatic mapping (7), the prognostic significance of MBD 
is unclear.
In the multi-institutional randomized Sunbelt Melanoma trial 
(3), 351 patients with MBD did not have worse outcomes; in fact 
their rate of locoregional recurrence was lower than that of the 
1,709 patients with single draining lymph node basins. However, 
a more recent series reported a higher rate of locoregional recur-
rence, shorter disease-free survival (DFS), and worse melanoma-
specific survival in 1,400 patients with MBD (6). Results of 
smaller studies also are conflicting (4, 5, 8, 9).
Our 1997 report showed that survival was worse in 120 
patients with dual-basin metastasis than in 124 patients with the 
same melanoma burden confined to a single basin (7). Dual-basin 
metastasis was associated with palpable nodes in 75% of first dis-
sected basins and 43% of second dissected basins. Additionally, 
the number of tumor-involved nodes was higher in patients with 
dual-basin metastasis than in those with single basin metastasis. 
However, this study predated the widespread use of lymphoscin-
tigraphy or SLN biopsy and all patients received regional lymph 
node dissections. In an effort to add to the current literature 
regarding the prognostic significance of MBD found with lym-
phatic mapping of cutaneous melanoma, we have reviewed our 
experience with this clinical scenario in the modern era. Unlike 
other retrospective studies, we used a matched-pair analysis to 
minimize bias in evaluating the true clinical significance of MBD 
in cutaneous melanoma.
MaTerials anD MeThODs
The melanoma database at the John Wayne Cancer Institute 
(JWCI) has been prospectively maintained for 40 years. Patients 
have signed written informed consent giving permission to collect 
tissue, blood, and clinical data for this database. Approval from 
the JWCI institutional review board was obtained for the current 
retrospective review and waived the need for additional informed 
consent for this study. We queried the database to identify all 
patients who underwent preoperative lymphoscintigraphy and 
sentinel node biopsy (SNB) for clinically localized melanoma. 
The study period was January 1991 to December 2010.
Preoperative lymphoscintigraphy and 
intraoperative lymphatic Mapping
We have previously reported the technical details of lym-
phoscintigraphy and SNB at the JWCI (10, 11). However, some 
details have changed slightly over time due to technological 
and pharmacologic improvements (12). Lymphoscintigraphy is 
performed approximately 2–4 h prior to the operative procedure. 
The operating surgeon marks the primary melanoma site (or the 
site of prior wide excision) and the patient is sent to the depart-
ment of nuclear medicine, where filtered technetium 99mTc sulfur 
colloid (0.5  mCi) is injected into the skin around the marked 
lesion. Sequential images from a scintillation camera are used to 
identify the sentinel lymph nodes and the sites are marked on the 
overlying skin.
The surgical procedure begins with intradermal injection of 
approximately 1 cc of 1% isosulfan blue dye (Lymphazurin) around 
the cutaneous melanoma biopsy site. Sentinel nodes are located 
intraoperatively with a gamma probe as well as by identifying and 
following the blue-stained lymphatic channels. Maximum in vivo 
and ex vivo radioactive counts of the sentinel node(s) and post 
biopsy basin counts are evaluated and recorded to ensure that all 
sentinel nodes have been excised. Sentinel nodes are sent to the 
department of pathology for evaluation of paraffin-fixed sections.
Our study included patients whose primary melanomas 
drained into basins in the cervical, supraclavicular, axillary, and 
inguinal chains. Supraclavicular nodes were only included as a 
separate lymph node basin for patients with melanomas of the 
upper back, trunk, and shoulder. It has been shown that 6–15% 
of melanomas in this area can have separate and distinct drain-
age patterns to both the axillary and/or supraclavicular nodes 
(13, 14). For head and neck melanomas, supraclavicular nodes 
were considered part of the cervical chain and not recorded as a 
separately draining lymph node basin. Epitrochlear and popliteal 
nodes were not considered separate basins from ipsilateral axil-
lary and inguinal lymph node basins, respectively.
Matching and statistical analysis
Patients with incomplete data on age, sex, Breslow depth, T stage, 
primary site, nodal status, and patients with mucosal melanomas 
were excluded from the study. The remaining patients were 
categorized into those who had single versus multiple draining 
lymph node basins identified on the lymphoscintigram and dur-
ing definitive operation. These patients were matched 1:1 by sex, 
anatomic site of primary melanoma, Breslow depth, age, and stage 
at diagnosis. Groups were compared before and after matching 
using the Chi-square test and ANOVA to determine if matching 
had been successful. Logistic regression was used to evaluate the 
significance of multiple lymph node basins, site of primary mela-
noma, Breslow depth, ulceration, and patient age as indicators of 
lymph node metastasis in the matched groups.
Our primary end points were overall survival (OS), disease-
specific survival (DSS), and DFS. Secondary endpoints included 
total recurrence, locoregional recurrence, and distant recurrence 
rates. Demographic and prognostic variables were compared by 
univariable and multivariable analyses using logistic regression to 
identify factors that may contribute to worse prognosis. Survival 
curves were constructed using the Kaplan–Meier log-rank test. 
Significance was set at p < 0.05.
resUlTs
Review of our database revealed 274 patients with multiple 
draining lymph node basins and 1,413 patients with single 
draining lymph node basins as identified by lymphoscintigraphy. 
Matching of these two groups yielded 259 pairs. Comparison of 
the matched pairs revealed that patient and tumor characteristics 
were similar for all matching statistics (p ≥ 0.84, Table 1).
Matched single basin drainage (SBD) and MBD groups each 
had 259 patients with 226 truncal lesions, 27 head and neck lesions, 
and 6 extremity lesions. Mean follow-up for matched groups was 
80.9  months. All patients in the MBD group had two or three 
TaBle 3 | Univariable and multivariable analyses of predictors of 10-year overall 
survival for matched cohorts.
Univariable Multivariable
hr (95% ci) hr (95% ci)
p Value p Value
Draining basinsa 0.82 (0.57–1.18) 0.75 (0.51–1.09)
One versus multi-basin 0.283 0.129
T stagea
T1: 0.01–1.00 0.10 (0.05–0.21) 0.17 (0.08–0.36)
T2: 1.00–2.00 0.42 (0.25–0.72) 0.50 (0.29–0.86)
T3: 2.01–4.00 0.70 (0.40–1.22) 0.74 (0.42–1.29)
T4: >4.00 (ref) <0.0001 <0.0001
Ulcerationa
Yes versus no 3.56 (2.40–5.28) 1.86 (1.22–1.83)
Unknown versus no 2.95 (1.59–5.48) 
<0.0001
1.57 (0.80–3.09) 
0.015
Agea 1.04 (1.02–1.05) 1.04 (1.02–1.05)
<0.0001 <0.0001
Sentinel lymph node (SLN) positivea 2.57 (1.78–3.72) 2.05 (1.38–3.04)
<0.0001 0.0004
Sitea NS
Extremity 0.40 (0.06–2.86)
Head/neck 1.64 (0.99–2.71)
Trunk (ref) 0.097^
Sexa 1.12 (0.73–1.71) NS
Male versus female 0.61
Stage III versus I/II 3.11 (2.15–4.48) –
<0.0001
aNumber of draining basins, T stage, ulceration, age, SLN positive, site, and sex are 
included in the stepwise model selection for multivariate analysis. Stage was not included 
in the stepwise model selection and therefore multivariable analysis is not applicable.
TaBle 2 | Sentinel lymph node (SLN) status for each individual draining basin in 
259 matched patients with multiple draining lymph node basins.
Basins mapped Positive sln N Frequency (%)
2 0 basins 181 69.9
1 basin 45 17.4
2 basins 16 6.18
3 0 basins 11 4.25
1 basin 5 1.93
2 basins 1 0.39
3 basins 0 0.0
Total 259 100
TaBle 1 | Patient demographics.
Matched
One basin Multiple basins p Value
Patients 259 259
sex 0.92
Male 192 191
Female 67 68
stage (presentation) 0.922
I/II 188 187
III 71 72
T stage 0.989
Unknown 8 7
T1 101 101
T2 83 83
T3 50 49
T4 17 19
site of primary 1.0
Extremity 6 6
Head/neck 27 27
Trunk 226 226
age 0.949
0–9 0 1
10–19 5 5
20–29 15 17
30–39 35 39
40–49 58 52
50–59 65 58
60–69 47 51
70–79 22 26
80+ 12 10
sentinel lymph node p = 0.8402
Positive 65 (25.1%) 67 (25.9%)
Negative 194 (74.9%) 192 (74.1%)
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Ten-year DFS revealed no difference between the matched 
groups (p = 0.64, Figure 3). Forty-four patients (17%) in the single 
basin group and 48 patients (18.5%) in the multiple basin group 
developed locoregional or distant recurrence (p =  0.65). There 
were 28 locoregional (10.8%) recurrences for the SBD group and 
32 (12.4%) for the MBD group (p = 0.58). Both groups had 16 
patients (6.2%) with distant recurrence (p = 1.0, Table 4). When 
evaluated by SLN status, there was no difference in recurrence 
rates for patients with a positive node in single (30.8%) or multiple 
(35.8%) draining basins (p = 0.54). This was also true for locore-
gional recurrences (p = 0.25) and distant recurrences (p = 0.53).
DiscUssiOn
Although other reports have shown that number of drainage basins 
from primary cutaneous melanoma does not affect survival (3, 4), 
draining basins (Table 2). MBD basins were located bilaterally in 
186 patients (67.6%) and unilaterally in 89 patients (32.4%). SLN 
positivity was 25% (n =  65) in the single basin group and 26% 
(n = 67) in the multiple basin group (p = 0.84). Of the patients with 
MBD and SLN metastasis, 45 patients had a positive SLN in only one 
of the two basins, 16 had positive SLN in the two separate basins, 1 
patient had positive SLN in 2 of the 3 basins, and 5 patients had a 
positive SLN in 1 of the 3 basins (Table 2). There was no difference 
in the mean number of positive nodes for patients with single basin 
(1.303) versus multiple basins (1.397) drainage (p = 0.5).
There was no significant difference in 10-year OS between the 
matched groups (p = 0.23, Figure 1A). Ten-year OS was 80.3% 
(CI: 0.75–0.85) for the single basin group compared to 75.7% (CI 
0.70–0.81) for the multiple basin group. There was no difference in 
10-year OS between the two groups that were either SLN negative 
(p = 0.579, Figure 1B) or SLN positive (p = 0.208, Figure 1C). 
SLN-positive patients showed no difference in 10-year OS whether 
they had positive nodes in single or multiple basins (Figure 1D). 
Similarly, DSS also showed no difference between the matched 
groups (p =  0.529, Figure 2). Ten-year DSS was 86.1% for the 
single basin group and 84.2% for the MBD group. Factors that 
were predictive of 10-year OS on multivariable analysis between 
the matched groups included Breslow depth, ulceration, positive 
SLN, and age (p ≤  0.008 for all variables). Multiple draining 
lymph node basins did not reach significance as a predictor of 
OS on multivariable analysis (p = 0.129, Table 3).
FigUre 3 | Ten-year disease-free survival for patients who had single versus 
multiple draining lymph node basins and were matched by standard 
prognostic factors.
FigUre 2 | Ten-year disease-specific survival for matched patients who had 
single versus multiple draining lymph node basins.
FigUre 1 | (a) Ten-year overall survival for matched patients who had single basin drainage (SBD) and multibasin drainage (MBD). Survival is also shown for (B) 
matched subgroups with tumor-negative sentinel lymph nodes (SLNs) and (c) tumor-positive SLNs. (D) Survival for SLN-positive patients is further categorized by 
single basin versus multibasin metastases.
4
Howard et al. Multibasin Nodal Drainage in Melanoma
Frontiers in Oncology | www.frontiersin.org August 2017 | Volume 7 | Article 172
ours is the first study to match MBD and SBD groups by patient-
related and tumor-related prognostic variables. The importance 
of prognostic matching is demonstrated by critical evaluation 
of studies that reported a survival impact of MBD but did not 
control for standard prognostic characteristics (15). For example, 
one published study found MBD to have an adverse impact on 
survival, independent of SLN positivity (8). However, the 76 MBD 
TaBle 4 | Comparison of 10-year overall survival (OS), disease-specific survival 
(DSS), disease-free survival (DFS), sentinel lymph node (SLN) positivity, and 
recurrence rates between matched patients with single versus multiple draining 
lymph node basins.
single Multiple p-Value
10-year OS 80.3% 75.7% 0.23
10-year DSS 86.1% 84.2% 0.53
10-year DFS 83.0% 81.5% 0.64
SLN+ 65 (25.1%) 67 (25.9%) 0.84
Recurrence (total) 20 (30.8%) 24 (35.8%) 0.54
Locoregional 12 (18.5%) 18 (26.9%) 0.25
Distant 8 (12.3%) 6 (9.0%) 0.53
Recurrence (total) 44 (17.0%) 48 (18.5%) 0.65
Locoregional 28 (10.8%) 32 (12.4%) 0.58
Distant 16 (6.2%) 16 (6.2%) 1.0
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patients had a significantly higher percentage of males and a non-
significantly higher rate of thick (>4 mm) primaries than the 190 
SBD patients. These imbalances might have contributed to the 
worse survival in the MBD group (16, 17). Similarly, another study 
linked MBD to a higher risk of lymph node metastases, but average 
Breslow thickness was non-significantly greater in MBD patients 
than SBD patients (5). It is known that melanomas located in dif-
ferent locations may have different behavior. Specifically head and 
neck melanoma have been shown to have poor survival and truncal 
melanomas are more likely to have positive sentinel nodes (15, 18). 
This is particularly important to this study as melanomas in these 
areas are the most likely to have MDB. By matching, we are able to 
compare patients with melanomas from the same anatomic areas 
and avoid comparing tumors from two different locations that may 
inherently have a different biology that could confound our results.
The data from the current study support no difference in sur-
vival for patients with SDB compared to MDB when matched by 
standard histopathologic prognostic factors. Ten-year OS curves 
for matched SLN-negative patients are very similar (Figure 1B). 
There is also no difference in 10-year OS for patients with single 
versus multiple draining basins that were sentinel node positive. 
However, while not statistically significant these curves do begin 
to show some separation at 10 years (Figure 1C), suggesting that 
perhaps a subset of MDB patients with SLN metastasis may have 
worse survival—we believe it is likely that those with metastases 
to be multiple basins (19). When 10-year OS is evaluated by the 
number of basins with a positive SLN (Figure 1D), the curves 
between patients with a single positive basin and multiple positive 
basins appear distinct, suggesting that patients with positive SLN 
in multiple basins may represent a subgroup of MDB patients 
with worse 10-year OS. While not reaching significance in the 
current study, this hypothesis is consistent with our previous study 
of patients with metastases in multiple basins, which concluded 
that the same total tumor burden of the regional nodes will carry 
a worse prognosis if it involves more than one lymphatic drainage 
basin (7). While having MBD on lymphoscintigraphy may not 
be a poor prognostic finding, it has been shown to be prognosti-
cally worse to have either microscopic or palpable positive nodes 
in multiple basins as compared to the same number of positive 
nodes in a single basin (7, 19). Thus having metastases in multiple 
basins may be the true indicator of poor prognosis, not simply 
finding drainage to multiple basins on lymphoscintigraphy. The 
nearly identical survival curves for patients with negative sentinel 
nodes (Figure 1B) and for patients with positive nodes in only 
one basin (Figure 1D) support this theory.
Most studies have shown that MBD does not correlate with SLN 
metastasis (3, 4, 8). The clinical finding with the most variability 
among studies is the rate of recurrence for patients with MBD. Several 
institutions have reported increased recurrence rates for patients 
with multiple basins (6, 8, 9), while one showed worse recurrence 
rates for patients with a single draining basin (3). We found that 
number of drainage basins did not affect DFS, overall recurrence, 
locoregional, or distant recurrence, regardless of SLN status.
Whether the phenomenon of MBD is purely based on anatomi-
cal location of the primary tumor or influenced by tumor biology 
remains unknown. Biologic factors that could theoretically 
increase the likelihood of multibasin drainage include ulcera-
tion, regression, lymphatic clogging, or possibly “collateral route” 
spread as a result of lymphangiogenesis induced by the primary 
tumor (8). Additionally, it has been suggested that tumors with 
MBD may be predisposed to distant, blood-borne metastases (8). 
Our findings do not rule out these hypotheses but do demonstrate 
that once appropriately controlled, the rate of developing distant 
metastases was identical between the two groups.
Despite our long follow-up and best efforts to minimize bias, 
the limitations of a single-institution retrospective study remain. 
Pathological findings including mitoses, ulceration, and regres-
sion were not routinely reported during our study period and 
were therefore not used to correlate survival or recurrence for 
the two groups. We are unable to comment on the independent 
significance of MBD on SLN metastasis in our matched groups 
since stage at presentation (which integrates the results of SNB) 
was one of the matching criteria and thus both groups had the 
same number of patients with regional microscopic metastases 
at presentation. By using stage at presentation as a matching 
criterion, we could compare long-term survival and recurrence 
data for two large groups of very similar patients. Had patients 
not been matched by stage, a disproportionate distribution of 
stage I/II and stage III cases could have biased survival and 
recurrence data. While multivariable analysis, and not match-
ing, may be the standard method of retrospectively evaluating 
two groups to correct for confounders and population hetero-
geneity, all previous studies of MBD have used these methods 
with conflicting results (3–6, 8, 9, 20). Given the inconsistent 
conclusions found with multivariable analysis, we hope to 
bring a new perspective to this clinical scenario by using the 
alternative statistical method of base pair matching to add to the 
understanding of the true prognostic value of MBD when found 
on lymphoscintigraphy.
Unlike several other studies, our data show no difference in OS 
or DFS of patients whose primary cutaneous melanoma drains to 
single versus multiple nodal basins (5, 6, 8, 9). This is the first study 
to evaluate this clinical scenario in a matched-pair analysis. MDB 
may only be a factor for 10-year OS for the small group of patients 
who have multiple SLN-positive basins compared to patients with 
the same disease burden in a single basin but our study is not 
powered to definitively make these conclusions. Our data sug-
gests that the clinical finding of MDB on lymphoscintigraphy 
6Howard et al. Multibasin Nodal Drainage in Melanoma
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does not necessarily portend a worse prognosis when compared 
to patients with similar primary tumors and only one draining 
basin. When patients have multiple draining lymph node basins 
from a primary cutaneous melanoma, each basin should be 
treated according to the standard of care and physicians can 
appropriately counsel patients based on the findings of SNB, pri-
mary tumor characteristics, and patient demographics in regard 
to treatment, surveillance, and prognosis.
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